The molecular mechanism of the angiogenic effect of laminin (Ln) was studied using human umbilical vein endothelial cells (HUVECs) maintained in culture on Ln-1 substratum. High-pressure liquid chromatography analysis showed that in cells maintained on Ln, the levels of proangiogenic prostaglandin E2 (PGE2) increased and that of antiangiogenic PGD2 decreased. The angiogenic effect of PGE2 and PGD2 was confirmed by assessing the expression of CD31 and E-selectin in HUVECs. Immunoblot analysis, reverse transcription-polymerase chain reaction and cyclooxygenase (COX) assay showed increase in the expression and activity of COX-2 in cells maintained on Ln. Use of pharmacological inhibitors suggested that the modulation in the expression of COX-2 and thereby the levels of PGE2 and PGD2 in endothelial cells by Ln is mediated through the α6β4 integrin-p38MAPK (mitogen-activated protein kinase)–NF-κB signaling pathway.
KimS, BellK, MousaSA, VarnerJA. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol2000;156:1345–62
2.
GeorgeEL, BaldwinHS, HynesRO. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood1997;90:3073–81
3.
EngbringJA, KleinmanHK. The basement membrane matrix in malignancy. J Pathol2003;200:465–70
4.
PatarroyoM, TryggvasonK, VirtanenI. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol2002;12:197–207
5.
DixeliusJ, JakobssonL, GenerschE, BohmanS, EkblomP, Claesson-WelshL. Laminin-1 promotes angiogenesis in synergy with fibroblast growth factor by distinct regulation of the gene and protein expression profile in endothelial cells. J Biol Chem2004;279:23766–72
6.
KumarVB, VijiRI, KiranMS, SudhakaranPR. Modulation of expression of LDH isoenzymes in endothelial cells by laminin: implications for angiogenesis. J Cell Biochem2008;103:1808–25
7.
WilliamsCS, MannM, DuBoisRN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene1999;18:7908–16
8.
JacksonJR, BologneseB, KircherCH, MarshallLA, WinklerJD. Modulation of angiogenesis in a model of chronic inflammation. Inflamm Res1997;46;2:S129–30
9.
DuboisRN, AbramsonSB, CroffordL, GuptaRA, SimonLS, Van De PutteLB, LipskyPE. Cyclooxygenase in biology and disease. FASEB J1998;12:1063–73
10.
ChurchmanA, BaydounAR, HoffmanR. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697). Eur J Pharmacol2007;573:176–83
11.
WuG, LuoJ, RanaJS, LahamR, SellkeFW, LiJ. Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res2006;69:512–19
12.
RueggC, DormondO, MariottiA. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis. Biochim Biophys Acta2004;1654:51–67
13.
Bishop-BaileyD, HlaT. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2. J Biol Chem1999;274:17042–8
14.
XinX, YangS, KowalskiJ, GerritsenME. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. J Biol Chem1999;274:9116–21
15.
RamsayRG, CiznadijaD, VanevskiM, MantamadiotisT. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control. Int J Immunopathol Pharmacol2003;16:59–67
16.
DixonDA. Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des2004;10:635–46
ZaricJ, RueggC. Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation. J Biol Chem2005;280:1077–85
19.
JaffeEA, NachmanRL, BeckerCG, MinickCR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest1973;52:2745–56
VijiRI, KumarVB, KiranMS, SudhakaranPR. Modulation of cyclooxygenase in endothelial cells by fibronectin: relevance to angiogenesis. J Cell Biochem2008;105:158–66
22.
HoltmannH, Shemer-AvniY, WesselK, SarovI, WallachD. Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis. Infect Immun1990;58:3168–72
23.
VijiRI, KumarVB, KiranMS, SudhakaranPR. Angiogenic response of endothelial cells to heparin-binding domain of fibronectin. Int J Biochem Cell Biol2008;40:215–26
24.
TowbinH, StaehelinT, GordonJ. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA1979;76:4350–4
25.
LowryOH, RosebroughNJ, FarrAL, RandallRJ. Protein measurement with the Folin phenol reagent. J Biol Chem1951;193:265–75
26.
EngvallE, PerlmannP. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry1971;8:871–4
27.
KumarVB, VijiRI, KiranMS, SudhakaranPR. Endothelial cell response to lactate: implication of PAR modification of VEGF. J Cell Physiol2007;211:477–85
28.
GaleanoM, AltavillaD, CucinottaD, RussoGT, CaloM, BittoA, MariniH, MariniR, AdamoEB, SeminaraP, MinutoliL, TorreV, SquadritoF. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes2004;53:2509–17
29.
WangJY, XuXY, JiaJH, WuCH, GeRW. Expressions of SE-1, CD31 and CD105 in the vascular endothelial cells and serum of rat with hepatocellular carcinoma. Chin Med J (Engl)123:730–3
30.
KralingBM, RazonMJ, BoonLM, ZurakowskiD, SeachordC, DarveauRP, MullikenJB, CorlessCL, BischoffJ. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol1996;148:1181–91
31.
SubbaramaiahK, MarmoTP, DixonDA, DannenbergAJ. Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. J Biol Chem2003;278:37637–47
32.
WeaverSA, RussoMP, WrightKL, KoliosG, JobinC, RobertsonDA, WardSG. Regulatory role of phosphatidylinositol 3-kinase on TNF-alpha-induced cyclooxygenase 2 expression in colonic epithelial cells. Gastroenterology2001;120:1117–27
33.
YangCM, ChienCS, HsiaoLD, LuoSF, WangCC. Interleukin-1beta-induced cyclooxygenase-2 expression is mediated through activation of p42/44 and p38 MAPKS, and NF-kappaB pathways in canine tracheal smooth muscle cells. Cell Signal2002;14:899–911
SawaokaH, TsujiS, TsujiiM, GunawanES, SasakiY, KawanoS, HoriM. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest1999;79:1469–77
37.
KiranMS, Sameer KumarVB, VijiRI, SudhakaranPR. Temporal relationship between MMP production and angiogenic process in HUVECs. Cell Biol Int2006;30:704–13
38.
Ben-AvP, CroffordLJ, WilderRL, HlaT. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett1995;372:83–7
39.
SalcedoR, ZhangX, YoungHA, MichaelN, WassermanK, MaWH, Martins-GreenM, MurphyWJ, OppenheimJJ. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood2003;102:1966–77
40.
TamuraK, SakuraiT, KogoH. Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vasc Pharmacol2006;44:411–16
41.
KumarVB, VijiRI, KiranMS, SudhakaranPR. Negative modulation of eNOS by laminin involving post-translational phosphorylation. J Cell Physiol2009;219:123–31
StrausDS, PascualG, LiM, WelchJS, RicoteM, HsiangCH, SengchanthalangsyLL, GhoshG, GlassCK. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA2000;97:4844–9
44.
RossiA, KapahiP, NatoliG, TakahashiT, ChenY, KarinM, SantoroMG. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature2000;403:103–8
45.
HuangS, PettawayCA, UeharaH, BucanaCD, FidlerIJ. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene2001;20:4188–97
